Hasan Turkmen Selected Research

Sulfanilamide

6/2011	Synthesis of sulfanilamide derivatives and investigation of in vitro inhibitory activities and antimicrobial and physical properties.
1/2005	Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hasan Turkmen Research Topics

Disease

4	Neoplasms (Cancer) 01/2017 - 01/2005
1	Chest Pain (Chest Pains) 01/2022
1	Syncope (Fainting) 01/2022
1	Glaucoma 06/2011

Drug/Important Bio-Agent (IBA)

4	Carbonic Anhydrases (Carbonic Anhydrase)IBA 03/2016 - 01/2005
3	IsoenzymesIBA 03/2016 - 01/2005
2	EnzymesIBA 01/2017 - 03/2016
2	Protein Isoforms (Isoforms)IBA 03/2016 - 06/2015
2	SulfonamidesIBA 03/2016 - 01/2005
2	Sulfanilamide FDA Link 06/2011 - 01/2005
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2005

Therapy/Procedure

1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022
1	Drug Therapy (Chemotherapy) 06/2011